Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Immunogenicity and Tolerability Study of FluvalAB FL-K-004 Trivalent Influenza Vaccine
- Status
- COMPLETED
- Phase
- NA
Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines
- Status
- COMPLETED
- Phase
- PHASE2
Influenza Vaccine Revaccination in Ambulatory Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly
- Status
- COMPLETED
- Phase
- PHASE3
Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
- Status
- COMPLETED
- Phase
- PHASE2
High Dose Influenza in Immunosuppressed Subjects
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older
- Status
- COMPLETED
- Phase
- PHASE3
Influenza Vaccine in HIV
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older
- Status
- COMPLETED
- Phase
- PHASE3
Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem
- Status
- UNKNOWN
- Phase
- NA
Efficacy of Influenza Vaccine in HIV Infected Adults
- Status
- COMPLETED
- Phase
- PHASE4
Randomized Control Trial to Study the Efficacy of the Surgical Mask Versus the N95 Respirator to Prevent Influenza
- Status
- COMPLETED
- Phase
- NA
Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®
- Status
- COMPLETED
- Phase
- PHASE4
Evaluate the Safety and Immunogenicity of a Seasonal Influenza VLP Vaccine (Recombinant) in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
- Status
- COMPLETED
- Phase
- PHASE3
Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age.
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE2